Cargando…
DLX2 promotes osteosarcoma epithelial-mesenchymal transition and doxorubicin resistance by enhancing HOXC8-CDH2 axis
Metastasis and doxorubicin resistance are challenges in the clinical diagnosis and treatment of osteosarcoma, the mechanisms underlying these phenomena remain unclear. In this study, we found that DLX2 is highly expressed in metastatic osteosarcoma and is closely related to clinical prognosis. Knock...
Autores principales: | Zhang, Boya, Du, Xinhui, Fan, Yichao, Qu, Guoxin, Pang, Lon Kai, Zhao, Ruiying, Yao, Weitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651674/ https://www.ncbi.nlm.nih.gov/pubmed/38026218 http://dx.doi.org/10.1016/j.isci.2023.108272 |
Ejemplares similares
-
Molecular mechanisms of osteosarcoma metastasis and possible treatment opportunities
por: Du, Xinhui, et al.
Publicado: (2023) -
DLX5 and HOXC8 enhance the chondrogenic differentiation potential of stem cells from apical papilla via LINC01013
por: Yang, Haoqing, et al.
Publicado: (2020) -
Posterior axis formation requires Dlx5/Dlx6 expression at the neural plate border
por: Narboux-Neme, Nicolas, et al.
Publicado: (2019) -
Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch
por: Lee, Su Yeon, et al.
Publicado: (2016) -
HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth
por: Han, Qicai, et al.
Publicado: (2023)